Literature DB >> 15188710

The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities.

M E Hellard1, J S Hocking, N Crofts.   

Abstract

This study measured the prevalence and the risk factors associated with HCV antibody-positive prisoners. A total of 630 prisoners completed a questionnaire about risk behaviours associated with HCV transmission and were tested for HCV antibody from a blood test. Of these 362 (57.5%) prisoners were HCV antibody positive. A total of 436 (68.8%) prisoners reported ever injecting drugs and 332 reported injecting drugs in prison. HCV-positive prisoners were more likely to have injected drugs (OR 29.9) and to have injected drugs in prison during their current incarceration (OR 3.0). Tattooing was an independent risk factor for being HCV positive (OR 2.7). This is the first study conducted on prisoners that has identified having a tattoo in prison as a risk factor for HCV. Injecting drugs whilst in prison during this incarceration was also a risk factor for HCV. Our results show prisoners who injected drugs outside of prison continue to inject in prison but in a less safe manner.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15188710      PMCID: PMC2870120          DOI: 10.1017/s0950268803001882

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  25 in total

Review 1.  HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response.

Authors:  Theodore M Hammett
Journal:  Am J Public Health       Date:  2006-01-31       Impact factor: 9.308

2.  Loss of virus-specific T-cell responses in HCV exposed uninfected injection drug users with drug rehabilitation.

Authors:  Prem H Thurairajah; Doha Hegazy; Andrew Demaine; Edward R Kaminski; Matthew E Cramp
Journal:  J Infect Dis       Date:  2011-03-15       Impact factor: 5.226

3.  Hepatitis C: Review of the Epidemiology, Clinical Care, and Continued Challenges in the Direct Acting Antiviral Era.

Authors:  Alexander J Millman; Noele P Nelson; Claudia Vellozzi
Journal:  Curr Epidemiol Rep       Date:  2017-04-20

4.  Prevalence of HCV risk behaviors among prison inmates: tattooing and injection drug use.

Authors:  Marisol Peña-Orellana; Adriana Hernández-Viver; Glorimar Caraballo-Correa; Carmen E Albizu-García
Journal:  J Health Care Poor Underserved       Date:  2011-08

5.  Global prevalence of hepatitis C in prisoners: a comprehensive systematic review and meta-analysis.

Authors:  Nader Salari; Niloofar Darvishi; Mahvan Hemmati; Shamarina Shohaimi; Yasaman Ghyasi; Farahnaz Hossaini; Mohammad-Rafi Bazrafshan; Hakimeh Akbari; Masoud Mohammadi
Journal:  Arch Virol       Date:  2022-02-14       Impact factor: 2.574

Review 6.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

7.  Correlates of incarceration among young methamphetamine users in Chiang Mai, Thailand.

Authors:  Nicholas Thomson; Catherine G Sutcliffe; Bangorn Sirirojn; Rassamee Keawvichit; Kanlaya Wongworapat; Kamolrawee Sintupat; Apinun Aramrattana; David D Celentano
Journal:  Am J Public Health       Date:  2008-10-15       Impact factor: 9.308

8.  HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection.

Authors:  Sofia R Bartlett; Brendan Jacka; Rowena A Bull; Fabio Luciani; Gail V Matthews; Francois M J Lamoury; Margaret E Hellard; Behzad Hajarizadeh; Suzy Teutsch; Bethany White; Lisa Maher; Gregory J Dore; Andrew R Lloyd; Jason Grebely; Tanya L Applegate
Journal:  Infect Genet Evol       Date:  2015-11-26       Impact factor: 3.342

9.  Testing for sexually transmitted infections and blood borne viruses on admission to Western Australian prisons.

Authors:  Rochelle E Watkins; Donna B Mak; Crystal Connelly
Journal:  BMC Public Health       Date:  2009-10-13       Impact factor: 3.295

10.  Viral hepatitis in correctional facilities in the Northern Territory of Australia 2003-2017.

Authors:  Richard P Sullivan; Rob Baird; Kevin Freeman; Hugh Heggie; Joshua S Davis; Catherine S Marshall; Jane Davies
Journal:  BMC Infect Dis       Date:  2021-06-16       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.